First-in-human phase I open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors. - Powderly JD 2nd; Gutierrez ME; Balmanoukian AS; Hoyle PE; Dong Z; Cheng L; Chen X; Janik JE; Bourayou N; Hamid O (The oncologist, 2025)